Ischemia-reperfusion injury in liver transplantation

Information

  • Research Project
  • 10475910
  • ApplicationId
    10475910
  • Core Project Number
    K08DK113244
  • Full Project Number
    3K08DK113244-05S1
  • Serial Number
    113244
  • FOA Number
    PA-16-191
  • Sub Project Id
  • Project Start Date
    9/15/2017 - 6 years ago
  • Project End Date
    10/31/2022 - a year ago
  • Program Officer Name
    SASLOWSKY, DAVID E
  • Budget Start Date
    8/1/2021 - 2 years ago
  • Budget End Date
    10/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
    S1
  • Award Notice Date
    9/15/2021 - 2 years ago
Organizations

Ischemia-reperfusion injury in liver transplantation

PROJECT SUMMARY The candidate, Dr. Ali Zarrinpar, presents a 5-year career development plan that seeks to characterize the relationship between pre-transplant neutrophil activity, ischemia/reperfusion injury (IRI), and eventual transplant outcomes while establishing an academic career as a physician-scientist in the field of surgery. IRI is the principal mechanism by which diseases such as myocardial infarction, stroke, and peripheral vascular disease cause their damage. It is also a major source of graft injury during organ transplantation. He and his colleagues have found that Bruton's tyrosine kinase (Btk) activity is important in liver IRI. Its selective inhibition blocks IR-induced hepatocellular damage and as a result protects the liver from subsequent severe inflammation. They also have conducted studies using specimens from human liver transplant recipients and found cytokines present in pre-transplant sera of recipients that predict the severity of IRI. These data suggest that recipients' pre-transplant immunologic milieu can influence IRI. These data have led them to hypothesize that measuring and modulating pre-transplant neutrophil activity will permit the selection, monitoring, and modulation of IRI, thereby improving liver transplant outcomes. This hypothesis will be pursued with two specific aims that investigate the relationship between neutrophil activity and IRI. Specific aim 1 tests the hypothesis that Btk activation potentiates neutrophil activation and promotes innate immune activity. This hypothesis will be tested both in vitro and in vivo using murine models. Specific aim 2 tests the hypothesis that heightened neutrophil activity before transplantation leads to increased IRI and subsequent activation of resident Kupffer cells and recruitment/activation of monocytes/macrophages and circulating T cells in human liver allografts, and that this pathological cascade perpetuates damage to the graft. This hypothesis will be tested using samples from human liver transplantation operations. Dr. Zarrinpar is well qualified to carry out the research outlined in this proposal. He has successfully completed projects of comparable complexity as part of his PhD thesis. He will train further by acquiring expertise in high quality IRI experiments and by studying immunology and cell biology. His mentor Dr. Jerzy Kupiec-Weglinski has decades long experience in studying transplant immunology and IRI. His co-mentor Dr. Stephen Bensinger provides expertise in studying the cell biology, signaling, and metabolic factors affecting the immune response. Dr. Ronald Busuttil, who has extensive experience training academic surgeons, will advise him on major career related issues and help navigate the academic promotion process. He will meet with his mentor and co-mentor monthly and meet with his surgical mentor every three months to discuss progress and to ensure a successful scientific program. Successful completion of the specific aims and career development plan outlined in this proposal will allow Dr. Zarrinpar to learn how to perform high quality immunology studies and to develop into an independent investigator in the field of surgery and immunology.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    K08
  • Administering IC
    DK
  • Application Type
    3
  • Direct Cost Amount
    35825
  • Indirect Cost Amount
    2866
  • Total Cost
    38691
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    847
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIDDK:38691\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    DDK
  • Study Section Name
    Kidney, Urologic and Hematologic Diseases D Subcommittee
  • Organization Name
    UNIVERSITY OF FLORIDA
  • Organization Department
    SURGERY
  • Organization DUNS
    969663814
  • Organization City
    GAINESVILLE
  • Organization State
    FL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    326115500
  • Organization District
    UNITED STATES